Skip to main content
SpringerLink
Log in

Venous Thromboembolism and Orthopedic Surgery

  • Chapter
  • First Online:
Perioperative Care of the Orthopedic Patient

  • 1404 Accesses

Abstract

Thromboembolic events are common and feared complications of orthopedic surgery, particularly lower extremity arthroplasty. Both patient and procedure-related risk factors have been identified. Prevention, an important tenant of orthopedic care, involves pharmacologic, nonpharmacologic approaches. This chapter presents a general overview of the problem of thromboembolism in the orthopedic setting.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 189.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Margaglione M, Grandone E. Population genetics of venous thromboembolism. A narrative review. Thromb Haemost. 2010;105(2):221–31.

    Article  PubMed  Google Scholar 

  2. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998;79(4):706–8.

    CAS  PubMed  Google Scholar 

  3. Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program 2005:1–12.

    Google Scholar 

  4. Delluc A, Gourhant L, Lacut K, Mercier B, Audrezet MP, Nowak E, Oger E, Leroyer C, Mottier D, Le Gal G, Couturaud F. Association of common genetic variations and idiopathic venous thromboembolism. Results from EDITh, a hospital-based case-control study. Thromb Haemost. 2010;103(6):1161–9.

    Article  CAS  PubMed  Google Scholar 

  5. Wahlander K, Larson G, Lindahl TL, Andersson C, Frison L, Gustafsson D, Bylock A, Eriksson BI. Factor V leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost. 2002;87(4):580–5.

    CAS  PubMed  Google Scholar 

  6. Westrich GH, Weksler BB, Glueck CJ, Blumenthal BF, Salvati EA. Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: an analysis of genetic factors. J Bone Joint Surg Am. 2002;84-A(12):2161–7.

    PubMed  Google Scholar 

  7. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44(2):62–9.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol. 2001;38(2 Suppl 5):12–9.

    Article  CAS  PubMed  Google Scholar 

  9. White RH, Zhou H, Gage BF. Effect of age on the incidence of venous thromboembolism after major surgery. J Thromb Haemost. 2004;2(8):1327–33.

    Article  CAS  PubMed  Google Scholar 

  10. Memtsoudis S, Liu SS, Ma Y, Chiu YL, Walz JM, Gaber-Baylis LK, Mazumdar M. Perioperative pulmonary outcomes in patients with sleep apnea after noncardiac surgery. Anesth Analg. 2011;112(1):113–21.

    Article  PubMed  Google Scholar 

  11. Imberti D, Bianchi C, Zambon A, Parodi A, Merlino L, Gallerani M, Corrao G. Venous thromboembolism after major orthopaedic surgery: a population-based cohort study. Intern Emerg Med. 2012;7(3):243–9.

    Article  PubMed  Google Scholar 

  12. Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am. 2010;92(12):2156–64.

    Article  CAS  PubMed  Google Scholar 

  13. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):338S–400.

    Article  CAS  PubMed  Google Scholar 

  14. Dahl OE, Pedersen T, Kierulf P, Westvik AB, Lund P, Arnesen H, Seljeflot I, Abdelnoor M, Lyberg T. Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res. 1993;70(6):451–8.

    Article  CAS  PubMed  Google Scholar 

  15. Sharrock NE, Go G, Harpel PC, Ranawat CS, Sculco TP, Salvati EA. The John Charnley award. Thrombogenesis during total hip arthroplasty. Clin Orthop Relat Res 1995;(319):16–27.

    Google Scholar 

  16. Nishiguchi M, Takamura N, Aoyagi K. Ximelagatran versus warfarin after total knee replacement. N Engl J Med. 2004;350(6):616–7. author reply 616–7.

    Article  PubMed  Google Scholar 

  17. Bae H, Westrich GH, Sculco TP, Salvati EA, Reich LM. The effect of preoperative donation of autologous blood on deep-vein thrombosis after total hip arthroplasty. J Bone Joint Surg Br. 2001;83(5):676–9.

    Article  CAS  PubMed  Google Scholar 

  18. Memtsoudis SG, Gonzalez Della Valle A, Besculides MC, Gaber L, Sculco TP. In-hospital complications and mortality of unilateral, bilateral, and revision TKA: based on an estimate of 4,159,661 discharges. Clin Orthop Relat Res. 2008;466(11):2617–27.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Warwick D, Friedman RJ, Agnelli G, Gil-Garay E, Johnson K, FitzGerald G, Turibio FM. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the global orthopaedic registry. J Bone Joint Surg Br. 2007;89(6):799–807.

    Article  CAS  PubMed  Google Scholar 

  20. Woller SC, Stevens SM, Jones JP, Lloyd JF, Evans RS, Aston VT, Elliott CG. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am J Med. 2011;124(10):947–954.e2.

    Article  PubMed  Google Scholar 

  21. Restrepo C, Parvizi J, Dietrich T, Einhorn TA. Safety of simultaneous bilateral total knee arthroplasty. A meta-analysis. J Bone Joint Surg Am. 2007;89(6):1220–6.

    Article  PubMed  Google Scholar 

  22. Bounameaux H, Miron MJ, Blanchard J, de Moerloose P, Hoffmeyer P, Leyvraz PF. Measurement of plasma D-dimer is not useful in the prediction or diagnosis of postoperative deep vein thrombosis in patients undergoing total knee arthroplasty. Blood Coagul Fibrinolysis. 1998;9(8):749–52.

    Article  CAS  PubMed  Google Scholar 

  23. Kearon C, Julian JA, Newman TE, Ginsberg JS. Noninvasive diagnosis of deep venous thrombosis. McMaster diagnostic imaging practice guidelines initiative. Ann Intern Med. 1998;128(8):663–77.

    Article  CAS  PubMed  Google Scholar 

  24. Hull R, Hirsh J, Sackett DL, Powers P, Turpie AG, Walker I. Combined use of leg scanning and impedance plethysmography in suspected venous thrombosis. An alternative to venography. N Engl J Med. 1977;296(26):1497–500.

    Article  CAS  PubMed  Google Scholar 

  25. Palareti G, Cosmi B, Legnani C. Diagnosis of deep vein thrombosis. Semin Thromb Hemost. 2006;32(7):659–72.

    Article  PubMed  Google Scholar 

  26. Anderson DR, Kahn SR, Rodger MA, Kovacs MJ, Morris T, Hirsch A, Lang E, Stiell I, Kovacs G, Dreyer J, Dennie C, Cartier Y, Barnes D, Burton E, Pleasance S, Skedgel C, O’Rouke K, Wells PS. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial. JAMA. 2007;298(23):2743–5.

    Article  CAS  PubMed  Google Scholar 

  27. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW, American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):381S–453.

    Article  CAS  PubMed  Google Scholar 

  28. Haas SB, Tribus CB, Insall JN, Becker MW, Windsor RE. The significance of calf thrombi after total knee arthroplasty. J Bone Joint Surg Br. 1992;74(6):799–802.

    CAS  PubMed  Google Scholar 

  29. Lotke PA, Palevsky H, Keenan AM, Meranze S, Steinberg ME, Ecker ML, Kelley MA. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop Relat Res. 1996;(324):251–8.

    Google Scholar 

  30. AAOS. Deep vein thrombosis: from the American Academy of Orthopaedic Surgeons. 2007. Accessed on November 24, 2010.

    Google Scholar 

  31. Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American association of orthopedic surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest. 2009;135(2):513–20.

    Article  PubMed  Google Scholar 

  32. AAOS. Guideline on preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. 2011.

    Google Scholar 

  33. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell Jr CW. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e278S–325.

    CAS  PubMed Central  PubMed  Google Scholar 

  34. Kearon C. Noninvasive diagnosis of deep vein thrombosis in postoperative patients. Semin Thromb Hemost. 2001;27(1):3–8.

    Article  CAS  PubMed  Google Scholar 

  35. Leclerc JR, Gent M, Hirsh J, Geerts WH, Ginsberg JS. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian collaborative group. Arch Intern Med. 1998;158(8):873–8.

    Article  CAS  PubMed  Google Scholar 

  36. Robinson KS, Anderson DR, Gross M, Petrie D, Leighton R, Stanish W, Alexander D, Mitchell M, Flemming B, Gent M. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Ann Intern Med. 1997;127(6):439–45.

    Article  CAS  PubMed  Google Scholar 

  37. Smith JS, Fu KM, Polly Jr DW, Sansur CA, Berven SH, Broadstone PA, Choma TJ, Goytan MJ, Noordeen HH, Knapp Jr DR, Hart RA, Donaldson 3rd WF, Perra JH, Boachie-Adjei O, Shaffrey CI. Complication rates of three common spine procedures and rates of thromboembolism following spine surgery based on 108,419 procedures: a report from the scoliosis research society morbidity and mortality committee. Spine (Phila Pa 1976). 2010;35(24):2140–9.

    Article  Google Scholar 

  38. Sansone JM, del Rio AM, Anderson PA. The prevalence of and specific risk factors for venous thromboembolic disease following elective spine surgery. J Bone Joint Surg Am. 2010;92(2):304–13.

    Article  PubMed  Google Scholar 

  39. Wirth T, Schneider B, Misselwitz F, Lomb M, Tuylu H, Egbring R, Griss P. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): results of a randomized controlled trial. Arthroscopy. 2001;17(4):393–9.

    Article  CAS  PubMed  Google Scholar 

  40. Michot M, Conen D, Holtz D, Erni D, Zumstein MD, Ruflin GB, Renner N. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy. 2002;18(3):257–63.

    Article  PubMed  Google Scholar 

  41. Camporese G, Bernardi E, Prandoni P, Noventa F, Verlato F, Simioni P, Ntita K, Salmistraro G, Frangos C, Rossi F, Cordova R, Franz F, Zucchetta P, Kontothanassis D, Andreozzi GM, KANT (Knee Arthroscopy Nadroparin Thromboprophylaxis) Study Group. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Ann Intern Med. 2008;149(2):73–82.

    Article  PubMed  Google Scholar 

  42. Demers C, Marcoux S, Ginsberg JS, Laroche F, Cloutier R, Poulin J. Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Arch Intern Med. 1998;158(1):47–50.

    Article  CAS  PubMed  Google Scholar 

  43. Willis AA, Warren RF, Craig EV, Adler RS, Cordasco FA, Lyman S, Fealy S. Deep vein thrombosis after reconstructive shoulder arthroplasty: a prospective observational study. J Shoulder Elbow Surg. 2009;18(1):100–6.

    Article  PubMed  Google Scholar 

  44. Sperling JW, Cofield RH. Pulmonary embolism following shoulder arthroplasty. J Bone Joint Surg Am. 2002;84-A(11):1939–41.

    PubMed  Google Scholar 

  45. Felcher AH, Mularski RA, Mosen DM, Kimes TM, DeLoughery TG, Laxson SE. Incidence and risk factors for venous thromboembolic disease in podiatric surgery. Chest. 2009;135(4):917–22.

    Article  PubMed  Google Scholar 

  46. Solis G, Saxby T. Incidence of DVT following surgery of the foot and ankle. Foot Ankle Int. 2002;23(5):411–4.

    PubMed  Google Scholar 

  47. Davidson HC, Mazzu D, Gage BF, Jeffrey RB. Screening for deep venous thrombosis in asymptomatic postoperative orthopedic patients using color doppler sonography: analysis of prevalence and risk factors. AJR Am J Roentgenol. 1996;166(3):659–62.

    Article  CAS  PubMed  Google Scholar 

  48. White RH, Gettner S, Newman JM, Trauner KB, Romano PS. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med. 2000;343(24):1758–64.

    Article  CAS  PubMed  Google Scholar 

  49. Westrich GH, Sculco TP. Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg Am. 1996;78(6):826–34.

    CAS  PubMed  Google Scholar 

  50. Haas SB, Insall JN, Scuderi GR, Windsor RE, Ghelman B. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am. 1990;72(1):27–31.

    CAS  PubMed  Google Scholar 

  51. Colwell Jr CW, Froimson MI, Mont MA, Ritter MA, Trousdale RT, Buehler KC, Spitzer A, Donaldson TK, Padgett DE. Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin. J Bone Joint Surg Am. 2010;92(3):527–35.

    Article  PubMed  Google Scholar 

  52. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):401S–28.

    Article  CAS  PubMed  Google Scholar 

  53. Bass AR, Mattern CJ, Voos JE, Peterson MG, Trost DW. Inferior vena cava filter placement in orthopedic surgery. Am J Orthop (Belle Mead NJ). 2010;39(9):435–9.

    Google Scholar 

  54. Young T, Aukes J, Hughes R, Tang H. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev 2007;(3):CD006212.

    Google Scholar 

  55. Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, Laporte S, Faivre R, Charbonnier B, Barral FG, Huet Y, Simonneau G. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du risque d’embolie pulmonaire par interruption cave study group. N Engl J Med. 1998;338(7):409–15.

    Article  CAS  PubMed  Google Scholar 

  56. Mesko JW, Brand RA, Iorio R, Gradisar I, Heekin R, Leighton R, Thornberry R. Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: a survey of the AAHKS membership. J Arthroplasty. 2001;16(6):679–88.

    Article  CAS  PubMed  Google Scholar 

  57. Friedman RJ, Gallus AS, Cushner FD, Fitzgerald G, Anderson Jr FA, Global Orthopaedic Registry Investigators. Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty. Curr Med Res Opin. 2008;24(1):87–9.

    Article  PubMed  Google Scholar 

  58. Berry DJ, Bozic KJ. Current practice patterns in primary hip and knee arthroplasty among members of the American association of hip and knee surgeons. J Arthroplasty. 2010;25(6 Suppl):2–4.

    Article  PubMed  Google Scholar 

  59. Anderson DR, Wilson SJ, Blundell J, Petrie D, Leighton R, Stanish W, Alexander D, Robinson KS, Burton E, Gross M. Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty. J Bone Joint Surg Am. 2002;84-A(11):1992–7.

    PubMed  Google Scholar 

  60. Asnis PD, Gardner MJ, Ranawat A, Leitzes AH, Peterson MG, Bass AR. The effectiveness of warfarin dosing from a nomogram compared with house staff dosing. J Arthroplasty. 2007;22(2):213–8.

    Article  PubMed  Google Scholar 

  61. Gage BF. Pharmacogenetics-based coumarin therapy. Hematology Am Soc Hematol Educ Program. 2006:467–73.

    Google Scholar 

  62. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, Brown DL, Heit JA, Mulroy MF, Rosenquist RW, Tryba M, Yuan CS. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition). Reg Anesth Pain Med. 2010;35(1):64–101.

    Article  CAS  PubMed  Google Scholar 

  63. Adam SS, McDuffie JR, Ortel TL, Williams Jr JW. Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review. Ann Intern Med. 2012;157(11):796–807.

    Article  PubMed  Google Scholar 

  64. Uchino K, Hernandez AV. Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials. Arch Intern Med. 2012;172(5):397–402.

    Article  CAS  PubMed  Google Scholar 

  65. Guijarro R, Montes J, San Roman C, Arcelus JI, Barillari G, Granero X, Monreal M. Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the spanish national discharge database. Thromb Haemost. 2010;105(4):610–5.

    Article  PubMed  Google Scholar 

  66. Freedman KB, Brookenthal KR, Fitzgerald Jr RH, Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am. 2000;82-A(7):929–38.

    CAS  PubMed  Google Scholar 

  67. Sharrock NE, Gonzalez Della Valle A, Go G, Lyman S, Salvati EA. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res. 2008;466(3):714–21.

    Article  PubMed Central  PubMed  Google Scholar 

  68. Hull R, Raskob G, Pineo G, Rosenbloom D, Evans W, Mallory T, Anquist K, Smith F, Hughes G, Green D. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med. 1993;329(19):1370–6.

    Article  CAS  PubMed  Google Scholar 

  69. Prandoni P, Bruchi O, Sabbion P, Tanduo C, Scudeller A, Sardella C, Errigo G, Pietrobelli F, Maso G, Girolami A. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med. 2002;162(17):1966–71.

    Article  CAS  PubMed  Google Scholar 

  70. Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Butcher M, Brant RF, Ghali WA, Bergqvist D, Raskob GE. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med. 2001;135(10):858–69.

    Article  CAS  PubMed  Google Scholar 

  71. Sobieraj DM, Lee S, Coleman CI, Tongbram V, Chen W, Colby J, Kluger J, Makanji S, Ashaye AO, White CM. Prolonged versus standard-duration venous thromboprophylaxis in major orthopedic surgery: a systematic review. Ann Intern Med. 2012;156(10):720–7.

    Article  PubMed  Google Scholar 

  72. PEP. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet. 2000;355(9212):1295–302.

    Article  Google Scholar 

  73. Westrich GH, Bottner F, Windsor RE, Laskin RS, Haas SB, Sculco TP. VenaFlow plus lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. J Arthroplasty. 2006;21(6 Suppl 2):139–43.

    Article  PubMed  Google Scholar 

  74. Huo MH, Salvati EA, Sharrock NE, Brien WW, Sculco TP, Pellicci PM, Mineo R, Go G. Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty. A prospective, randomized, controlled, clinical trial. Clin Orthop Relat Res 1992;(274):35–46.

    Google Scholar 

  75. Salvati EA. Multimodal prophylaxis of venous thrombosis. Am J Orthop (Belle Mead NJ). 2002;31(9 Suppl):4–11.

    Google Scholar 

  76. Salvati EA, Sharrock NE, Westrich G, Potter HG, Valle AG, Sculco TP. The 2007 ABJS Nicolas Andry award: three decades of clinical, basic, and applied research on thromboembolic disease after THA: rationale and clinical results of a multimodal prophylaxis protocol. Clin Orthop Relat Res. 2007;459:246–54.

    Article  PubMed  Google Scholar 

  77. Westrich GH, Menezes A, Sharrock N, Sculco TP. Thromboembolic disease prophylaxis in total knee arthroplasty using intraoperative heparin and postoperative pneumatic foot compression. J Arthroplasty. 1999;14(6):651–6.

    Article  CAS  PubMed  Google Scholar 

  78. Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W, RECORD1 Study Group. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 2008;358(26):2765–7.

    Article  CAS  PubMed  Google Scholar 

  79. Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, Misselwitz F, Turpie AG, RECORD3 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008;358(26):2776–8.

    Article  CAS  PubMed  Google Scholar 

  80. Jameson SS, Rymaszewska M, Hui AC, James P, Serrano-Pedraza I, Muller SD. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty. J Bone Joint Surg Am. 2012;94(17):1554–8.

    Article  PubMed  Google Scholar 

  81. Jensen CD, Steval A, Partington PF, Reed MR, Muller SD. Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study. J Bone Joint Surg Br. 2011;93(1):91–5.

    Article  CAS  PubMed  Google Scholar 

  82. Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Kalebo P, Christiansen AV, Hantel S, Hettiarachchi R, Schnee J, Buller HR, RE-MODEL Study Group. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost. 2007;5(11):2178–85.

    Article  CAS  PubMed  Google Scholar 

  83. Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Prins MH, Hettiarachchi R, Hantel S, Schnee J, Buller HR, RE-NOVATE Study Group. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet. 2007;370(9591):949–56.

    Article  CAS  PubMed  Google Scholar 

  84. Bozic KJ, Vail TP, Pekow PS, Maselli JH, Lindenauer PK, Auerbach AD. Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? J Arthroplasty. 2010;25(7):1053–60.

    Article  PubMed  Google Scholar 

  85. Todd CJ, Freeman CJ, Camilleri-Ferrante C, Palmer CR, Hyder A, Laxton CE, Parker MJ, Payne BV, Rushton N. Differences in mortality after fracture of hip: the East Anglian audit. BMJ. 1995;310(6984):904–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  86. Turpie AG, Bauer KA, Eriksson BI, Lassen MR, PENTATHALON 2000 Study Steering Committee. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet. 2002;359(9319):1721–6.

    Article  CAS  PubMed  Google Scholar 

  87. Eriksson BI, Bauer KA, Lassen MR, Turpie AG, Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001;345(18):1298–304.

    Article  CAS  PubMed  Google Scholar 

  88. Wen DY, Hall WA. Complications of subcutaneous low-dose heparin therapy in neurosurgical patients. Surg Neurol. 1998;50(6):521–5.

    Article  CAS  PubMed  Google Scholar 

  89. Gerlach R, Raabe A, Beck J, Woszczyk A, Seifert V. Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery. Eur Spine J. 2004;13(1):9–13.

    Article  PubMed Central  PubMed  Google Scholar 

  90. Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Portman RJ. Apixaban or enoxaparin for thromboprophylaxis after knee replacement. N Engl J Med. 2009;361(6):594–604.

    Article  CAS  PubMed  Google Scholar 

  91. Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM, ADVANCE-3 Investigators. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010;363(26):2487–98.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, USA

    Anne R. Bass

Authors
  1. Anne R. Bass
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne R. Bass .

Editor information

Editors and Affiliations

  1. Department of Medicine, Hospital for Special Surgery, New York, New York, USA

    C. Ronald MacKenzie

  2. Department of Orthopedic Surgery, Hospital for Special Surgery, New York, New York, USA

    Charles N. Cornell

  3. Department of Anesthesiology, Hospital for Special Surgery, New York, New York, USA

    Stavros G. Memtsoudis

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer New York

About this chapter

Cite this chapter

Bass, A.R. (2014). Venous Thromboembolism and Orthopedic Surgery. In: MacKenzie, C., Cornell, C., Memtsoudis, S. (eds) Perioperative Care of the Orthopedic Patient. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0100-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-0100-1_19

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-0099-8

  • Online ISBN: 978-1-4614-0100-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation